Our discovery scientists “strive to make the impossible possible,” says Joe Miletich. And he should know: As the senior vice president of Discovery Preclinical and Early Development, he leads a team of researchers who are charged with making things “possible that weren’t possible before.” He continues: “We believe drug discovery is foundational for us to continue bringing critical medicines to the world.”
About 12,000 people are involved in scientific research at MSD. Our R&D colleagues are all tasked with the same mission: to solve the puzzles of human disease biology and then translate those findings into new therapies for patients. They are driven to push the boundaries of science and to then transform their discoveries into meaningful new therapeutics.
“We aim to translate a piece of science into a really effective medicine or vaccine, taking a piece of science all the way to becoming a truly impactful therapeutic – nothing short of that is our ultimate goal.”
“I think we always have a sense of urgency,” says Daria Hazuda, vice president of Infectious Diseases and Vaccines Discovery, and chief scientific officer of our recently launched Cambridge Massachusetts Exploratory Science Center. “We’re always driven to push the envelope, to push the frontier, to do something that nobody’s ever done before.”
“The ‘inspiration to invent’ remains our driving passion – and a proven path to dramatic advances in human health.”
people are involved in our R&D. They share a commitment to turn breakthrough science into meaningful therapeutic options for patients.